12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 6: Pulmonary Symp<strong>to</strong>mssensation of severe dyspnea. Addition of barbiturates often helps <strong>to</strong> maintain sedation <strong>and</strong> reducerequired doses of benzodiazepines. Pen<strong>to</strong>barbital, 100 <strong>to</strong> 200 mg, can be administeredorally, rectally or parenterally every 3 <strong>to</strong> 4 hours as needed. Phenobarbital doses of 60 <strong>to</strong> 120 mgcan be26givenpicasby similar routes every 6 <strong>to</strong> 12 hours. Doses of drugs need <strong>to</strong> be adjusted frequently<strong>and</strong> the patient may require extraordinarily high doses of medications (5 <strong>to</strong> 15 mg/hour ofmidazolam) <strong>to</strong> maintain com<strong>for</strong>t as the airway obstruction progresses. However, with carefulattention <strong>to</strong> the details of dosing, continuous sedation <strong>and</strong> a peaceful death are possible.<strong>Palliative</strong> Treatment of Respira<strong>to</strong>ry DepressionWhen serious respira<strong>to</strong>ry depression occurs from excess opiods, patients respond well <strong>to</strong> carefultitration of naloxone. One ampule of 0.4 mg of naloxone can be diluted in 9 ml of saline <strong>and</strong> thenone ml (0.04 mg) of this solution can be injected every five minutes until specific symp<strong>to</strong>ms suchas respira<strong>to</strong>ry depression or hypotension are reversed. <strong>The</strong> goal is <strong>to</strong> treat the symp<strong>to</strong>ms <strong>and</strong> not<strong>to</strong> <strong>to</strong>tally reverse the opioid effect. <strong>The</strong> doses required <strong>to</strong> treat life-threatening symp<strong>to</strong>ms usuallyare not disturbing <strong>to</strong> the recipient <strong>and</strong> often do not even awaken the patient.CONCLUSION■ Caring <strong>for</strong> people who are terminally ill is a unique, but rewarding, challenge <strong>for</strong> health careproviders. As patients face progressive, incurable diseases, we are now able <strong>to</strong> reassure themthat even their most distressing physical symp<strong>to</strong>ms can be relieved. <strong>The</strong> less obvious sources ofdistress, such as loss of independence, anxiety about being a burden <strong>to</strong> family, unfulfilled dreams,the impending separation from loved ones, unresolved conflicts or guilt, <strong>and</strong> the need <strong>to</strong> redefinethe goals <strong>and</strong> purpose of life, also require attention. In addition <strong>to</strong> effective symp<strong>to</strong>m management,out patients need a safe environment, willing listeners, <strong>and</strong> a sense of being valued. <strong>The</strong>y alsoneed accurate in<strong>for</strong>mation about their disease, an underst<strong>and</strong>ing of treatment options, ideas ofwhat <strong>to</strong> expect in the future, <strong>and</strong> as much control of their lives as possible. When these needs aremet, the majority of terminally ill people experience a peaceful <strong>and</strong> com<strong>for</strong>table death.154U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!